Eli Lilly Price
1,133.00₺ %-2.41-27.95
Last update:
High1.169,99 ₺
Low1.132,81 ₺
Volume2.43M
Market Cap1.01T
52W Low: 623.7840.30%52W High: 1,182.73
After-Hours1,134.000.09%
- Open
- 1,165.00
- P/E
- 40.32
- Forward P/E
- 25.47
- P/B
- 32.45
- EPS (TTM)
- 28.10
- Forward EPS
- 44.4899
- Book Value
- 34.917
- Dividend Yield
- 0.54% (6.23)
- Dividend Date
- Jun 10, 2026
- 50-Day Avg
- 996.783
- 200-Day Avg
- 958.4459
- Avg Volume (3M)
- 3.23M
- Shares Outstanding
- 891.74M
- Bid / Ask
- 1,133.33 / 1,137.00
- Analyst Rating
- 1.7 - Buy
- Next Earnings
- Aug 5, 2026
- Exchange
- NYSE
- Market State
- Closed
Company Data
Healthcare · Drug Manufacturers - General · 50000 employees
| Forward P/E | 25.47 |
|---|---|
| PEG Ratio | 1.52 |
| Price/Book | 32.45 |
| Beta | 0.52 |
| Earnings Per Share (EPS) | 28.1 |
| 52-Week Change | %40.3 |
| Enterprise Value (EV) | 1T |
| Shares Outstanding | 891.7M |
| Last Dividend | 1.73 (May 15, 2026) |
| Insider Ownership | %0.16 |
| Institutional Ownership | %85.33 |
| Net Profit Margin | %34.99 |
|---|---|
| Operating Margin | %49.39 |
| Return on Equity (ROE) | %107.46 |
| Return on Assets (ROA) | %20.74 |
| Revenue Growth | %55.5 |
| Earnings Growth | %169.9 |
| Debt/Equity | 139.02 |
| Current Ratio | 1.5 |
Analyst Outlook
- Average Price Target
- 1,215.79
- Target Range
- 850 – 1,500
- Number of Analysts
- 29
- Consensus
- Buy
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 6 | 18 | 5 | 1 | 1 |
Company data is sourced from Yahoo Finance and may be delayed; this is not investment advice.
Eli Lilly News
- Is Eli Lilly (LLY) One Of The Most Profitable Blue Chip Stocks To Buy According To Hedge Funds?
- Lilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026 EHA Annual Meeting
- Jim Cramer Wasn’t Selling Eli Lilly (LLY)
- Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know
- Eli Lilly (LLY) Moves to Enforce 340B Claims Data Reporting Compliance
- Goldman Sachs Maintains a Buy Rating on Eli Lilly (LLY), Cites Encouraging Obesity Treatment Pipeline
News is sourced from Yahoo Finance; headlines link to external sources.
What Is Eli Lilly?
Eli Lilly (LLY) is a company share traded on Borsa İstanbul. This page shows the last trade price, daily change, and intraday movement for Eli Lilly. Data is updated during Borsa İstanbul session hours.
The Eli Lilly price is determined by supply and demand. The company's financial performance, sector dynamics, and the macro environment are the main determinants.
Factors Affecting the Eli Lilly Price
- Company quarterly financial results (EBITDA, net profit)
- Sector dynamics and the competitive environment
- Dividend policy and capital increase decisions
- Inclusion in/exclusion from BIST indices (liquidity effect)
- Macro conditions and the foreign ownership ratio
Frequently Asked Questions
- What is Eli Lilly?
- Eli Lilly (LLY) is a publicly traded company on Borsa İstanbul. Its shares are bought and sold under the symbol "LLY".
- What are the Eli Lilly trading hours?
- On Borsa İstanbul, pre-opening is 09:40-09:55 and continuous trading is 10:00-18:00 (lunch break 13:00-14:00).
- How is the Eli Lilly price determined?
- It is the last trade price at which buyer and seller are matched in the continuous auction system. The best bid and ask levels in the order book indicate liquidity.
- When does dividend distribution for Eli Lilly occur?
- Eli Lilly dividend distribution is determined by a general assembly decision; for past-year dividends you can follow the PDP (KAP) announcements.